BBHC
RGEN icon

Brown Brothers Harriman & Co’s Repligen RGEN Stock Holding History

Brown Brothers Harriman & Co’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$19K – 1462
2022
Q3 		$19K Buy
+100
New +$21.1K ﹤0.01% 988

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Brown Brothers Harriman & Co's RGEN Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Repligen (RGEN) in Q4 2022, closing a stake of 100 shares — an estimated $19K sold.

Brown Brothers Harriman & Co first reported a position in RGEN in Q3 2022 and held it in 1 quarter. The position peaked at $19K in Q3 2022. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 100 Repligen shares in Q4 2022, an estimated $19K.
  • Brown Brothers Harriman & Co first reported a position in Repligen in Q3 2022 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Repligen position peaked at $19K in Q3 2022.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.